Showing results (1-10 of 437) with videos related to
Sort By:
Pageof 44
Endocrine-Related Cancer|April 13, 2017
Molecular imaging in the investigation of hypoglycaemic syndromes and their managementDavid A Pattison, Rodney J HicksCancer Imaging : the Official Publication of the International Cancer Imaging Society|September 23, 2020
The utility of pharmacological and radiological interventions to optimize diagnostic information from PET/CTDavid Dudoignon, David A Pattison, Damien Legallois, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 14, 2017
18F-FDG-Avid Thyroid Incidentalomas: The Importance of Contextual InterpretationDavid A Pattison, Michael Bozin, Alexandra Gorelik, et al.EJNMMI Research|February 10, 2019
Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CTDavid A Pattison, Lisa L MacFarlane, Jason Callahan, et al.Internal Medicine Journal|December 14, 2020
Utility of 68 Ga-DOTA-Exendin-4 positron emission tomography-computed tomography imaging in distinguishing between insulinoma and nesidioblastosis in patients with confirmed endogenous hyperinsulinaemic hypoglycaemiaVictor Kalff, Amir Iravani, Timothy Akhurst, et al.Journal of Critical Care|September 15, 2020
Octreotide for resuscitation of cardiac arrest due to carcinoid crisis precipitated by novel peptide receptor radionuclide therapy (PRRT): A case reportJayesh Dhanani, David A Pattison, Matthew Burge, et al.Clinical Case Reports|April 12, 2018
Diagnostic challenges in a patient with an occult insulinoma:68 Ga-DOTA-exendin-4 PET/CT and 68Ga-DOTATATE PET/CTElisa Bongetti, Melissa H Lee, David A Pattison, et al.European Journal of Nuclear Medicine and Molecular Imaging|September 29, 2016
High clinical and morphologic response using 90Y-DOTA-octreotate sequenced with 177Lu-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumoursGrace Kong, Jason Callahan, Michael S Hofman, et al.Cancer Imaging : the Official Publication of the International Cancer Imaging Society|August 19, 2016
(68)Ga-DOTATATE and (18)F-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneityChian A Chang, David A Pattison, Richard W Tothill, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 22, 2009
Role of 18F-FDG PET in assessment of response in non-small cell lung cancerRodney J HicksPageof 44